IL-3 BLOCKADE IN SYSTEMIC LUPUS ERYTHEMATOSUS AND MULTIPLE SCLEROSIS

摘要

The present invention relates to anti-IL-3 antibodies or IL-3 binding fragments thereof for use in the treatment of an autoimmune disease selected from the group consisting of systemic lupus erythematosus and multiple sclerosis, and to pharmaceutical compositions comprising such an antibody or antibody fragment.